about
Reduced first-phase insulin secretion increases postprandial lipidemia in subjects with impaired glucose toleranceParticle number analysis of lipoprotein subclasses by gel permeation HPLC in patients with cholesteryl ester transfer protein deficiency.The Canadian laboratory initiative on pediatric reference intervals: A CALIPER white paper.Effects of a Dipeptidyl Peptidase 4 Inhibitor Sitagliptin on Glycemic Control and Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus (GLORIA Trial).Effects of a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator K-877 (Pemafibrate) on Postprandial hyperlipidemia.A Novel Selective PPARα Modulator (SPPARMα), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in Mice.Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial.Glucose and Fat Tolerance Tests Induce Differential Responses in Plasma Choline Metabolites in Healthy Subjects
P2860
Q33883131-CC4502C4-F4F1-443B-8D6B-E2699E827BD8Q47229897-54BDE5C7-B035-4C23-BD94-E879444AC258Q47247393-6CC32F52-567D-48E7-8732-83C49BCEBCF4Q49334569-A3B36D51-62B7-4108-B92A-B8BFD678A475Q50091421-96351163-EAF7-473E-9E0C-8B9370328F95Q50320306-760A9A03-026A-4E71-9CF5-F50F060A8D45Q52599940-EDCF4A4C-6929-4BCA-8C35-E7C6929A68ECQ58773211-83CE50F5-8101-4AD9-BC33-5E7FC5CD29A0
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Postprandial Hyperlipidemia and Remnant Lipoproteins.
@en
Postprandial Hyperlipidemia and Remnant Lipoproteins.
@nl
type
label
Postprandial Hyperlipidemia and Remnant Lipoproteins.
@en
Postprandial Hyperlipidemia and Remnant Lipoproteins.
@nl
prefLabel
Postprandial Hyperlipidemia and Remnant Lipoproteins.
@en
Postprandial Hyperlipidemia and Remnant Lipoproteins.
@nl
P2860
P921
P356
P1476
Postprandial Hyperlipidemia and Remnant Lipoproteins.
@en
P2093
Daisaku Masuda
Shizuya Yamashita
P2860
P304
P356
10.5551/JAT.RV16003
P577
2016-11-08T00:00:00Z
2017-02-01T00:00:00Z